Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox
Open accessAbstract
Adipocytes produce adipokines, including chemerin, a chemoattractant that mediates effects through its ChemR23 receptor. Chemerin has been linked to endothelial dysfunction and vascular injury in pathological conditions, such as obesity, diabetes mellitus, and hypertension. Molecular mechanisms underlying this are elusive. Here we assessed whether chemerin through redox-sensitive signaling influences molecular processes associated with vascular growth, apoptosis, and inflammation. Human microvascular endothelial cells and vascular smooth muscle cells were stimulated with chemerin (50 ng/mL). Chemerin increased generation of reactive oxygen species and phosphorylation of mitogen-activated protein kinases, effects that were inhibited by ML171, GKT137831 (Nox inhibitors), and N-acetylcysteine (reactive oxygen species scavenger). Chemerin increased mRNA expression of proinflammatory mediators in vascular cells and increased monocyte-to-endothelial cell attachment. In human vascular smooth muscle cells, chemerin induced phosphorylation of mitogen-activated protein kinases and stimulated proliferation (increased proliferating cell nuclear antigen expression [proliferation marker] and BrdU incorporation [proliferation assay]). Chemerin decreased phosphatidylinositol 3-kinase/protein kinase B activation and increased TUNEL-positive human vascular smooth muscle cells. In human microvascular endothelial cells, chemerin reduced endothelial nitric oxide synthase activity and nitric oxide production. Adipocyte-conditioned medium from obese/diabetic mice (db/db), which have elevated chemerin levels, increased reactive oxygen species generation in vascular smooth muscle cells, whereas adipocyte-conditioned medium from control mice had no effect. Chemerin actions were blocked by CCX 832, a ChemR23 inhibitor. Our data demonstrate that chemerin, through Nox activation and redox-sensitive mitogen-activated protein kinases signaling, exerts proapoptotic, proinflammatory, and proliferative effects in human vascular cells. These findings elucidate some molecular mechanisms through chemerin, which is increased in obesity, whereby adipocytes may influence vascular function. We identify chemerin as a novel vasoactive adipokine, which may be important in obesity-related vascular injury.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chemerin is chemotactic for M1-like macrophages, exerts pro-inflammatory effects, and increases reactive oxygen species production in vascular cells.
“Chemerin is a chemotactic molecule for M1-like macrophages114, exerts pro-inflammatory effects and increases the production of reactive oxygen species in vascular cells120.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · see citing works
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165 · see citing works
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608 · see citing works
Relationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · see citing works
Wittamer, V., Franssen, J.-D., Vulcano, M., Mirjolet, J.-F., Le Poul, E., Migeotte, I., Brézillon, S., Tyldesley, R., Blanpain, C., Detheux, M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030382 · Cited by 888 · see citing works
Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome
Bozaoglu, K., Bolton, K. A., McMillan, J. S., Zimmet, P., Jowett, J. B. M., Collier, G. R., Walder, K. R., & Segal, D. (2007) · Endocrinology · doi:10.1210/en.2007-0175 · Cited by 859 · see citing works
Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism
Goralski, K. B., McCarthy, T. C., Hanniman, E. A., Zabel, B. A., Butcher, E. C., Parlee, S. D., Muruganandan, S., & Sinal, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700793200 · Cited by 851 · see citing works
Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Matsuzawa, Y. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0380 · Cited by 434 · see citing works
Chemerin: at the crossroads of inflammation and obesity
Ernst, M. C., & Sinal, C. J. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.08.001 · Cited by 428 · see citing works
Sell, H., Laurencikiene, J., Taube, A., Eckardt, K., Cramer, A., Horrighs, A., Arner, P., & Eckel, J. (2009) · Diabetes · doi:10.2337/db09-0277 · Cited by 389 · see citing works
Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190223 · Cited by 375 · see citing works
Self-citationChemerin—A new adipokine that modulates adipogenesis via its own receptor
Roh, S., Song, S.-H., Choi, K.-C., Katoh, K., Wittamer, V., Parmentier, M., & Sasaki, S.-I. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.104 · Cited by 361 · see citing works
Kaur, J., Adya, R., Tan, B. K., Chen, J., & Randeva, H. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.150 · Cited by 349 · see citing works
Lehrke, M., Becker, A., Greif, M., Stark, R. G., Laubender, R. P., von Ziegler, F., Lebherz, C., Tittus, J., Reiser, M. F., Becker, C. R., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0380 · Cited by 300 · see citing works
Zabel, B. A., Nakae, S., Zuniga, L. A., Kim, J., Ohyama, T., Alt, C., Pan, J., Suto, H., Soler, D. F., Allen, S. J., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080300 · Cited by 298 · see citing works
Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes
Weigert, J., Neumeier, M., Wanninger, J., Filarsky, M., Bauer, S., Wiest, R., Farkas, S. A., Scherer, M. N., Schäffler, A., Aslanidis, C., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03664.x · Cited by 292 · see citing works
Towards an integrative approach to understanding the role of chemerin in human health and disease
Rourke, J. L., Dranse, H. J., & Sinal, C. J. (2012) · Obesity Reviews · doi:10.1111/obr.12009 · Cited by 282 · see citing works
Resistin, Obesity, and Insulin Resistance — The Emerging Role of the Adipocyte as an Endocrine Organ
Shuldiner, A. R., Yang, R., & Gong, D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200111013451814 · Cited by 263 · see citing works
Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes
Ernst, M. C., Issa, M. E., Goralski, K. B., & Sinal, C. J. (2010) · Endocrinology · doi:10.1210/en.2009-1098 · Cited by 260 · see citing works
Ghouleh, I. A., Khoo, N. K. H., Knaus, U. G., Griendling, K. K., Touyz, R. M., Thannickal, V. J., Barchowsky, A., Nauseef, W. M., Kelley, E. E., Bauer, P. M., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.011 · Cited by 249 · see citing works
Self-citationRedox‐dependent signalling by angiotensin II and vascular remodelling in hypertension
Touyz, R. M., Tabet, F., & Schiffrin, E. L. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03930.x · Cited by 236 · see citing works
Self-citationO tecido adiposo como centro regulador do metabolismo
Fonseca‐Alaniz, M. H., Takada, J., Alonso‐Vale, M. I. C., & Lima, F. B. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200008 · Cited by 219 · see citing works
Wittamer, V., Grégoire, F., Robberecht, P., Vassart, G., Communi, D., & Parmentier, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313016200 · Cited by 206 · see citing works
Hart, R., & Greaves, D. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902154 · Cited by 175 · see citing works
Ernst, M. C., Haidl, I. D., Zuniga, L. A., Dranse, H. J., Rourke, J. L., Zabel, B. A., Butcher, E. C., & Sinal, C. J. (2011) · Endocrinology · doi:10.1210/en.2011-1490 · Cited by 171 · see citing works
Chemerin/chemR23 axis in inflammation onset and resolution
Mariani, F., & Roncucci, L. (2014) · Inflammation Research · doi:10.1007/s00011-014-0792-7 · Cited by 162 · see citing works
Effects of Adipocyte-Derived Cytokines on Endothelial Functions: Implication of Vascular Disease
Kougias, P., Chai, H., Lin, P. H., Yao, Q. C., Lumsden, A. B., & Chen, C. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2004.12.023 · Cited by 161 · see citing works
Jialal, I., Devaraj, S., Kaur, H., ADAMS-HUET, B. A., & Bremer, A. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3673 · Cited by 155 · see citing works
Serum Chemerin Levels Vary with Time of Day and Are Modified by Obesity and Tumor Necrosis Factor-α
Parlee, S. D., Ernst, M. C., Muruganandan, S., Sinal, C. J., & Goralski, K. B. (2010) · Endocrinology · doi:10.1210/en.2009-0794 · Cited by 151 · see citing works
Chemerin regulates β-cell function in mice
Takahashi, M., Okimura, Y., Iguchi, G., Nishizawa, H., Yamamoto, M., Suda, K., Kitazawa, R., Fujimoto, W., Takahashi, K., Zolotaryov, F. N., et al. (2011) · Scientific Reports · doi:10.1038/srep00123 · Cited by 149 · see citing works
Chemerin Connects Fat to Arterial Contraction
Watts, S. W., Dorrance, A. M., Penfold, M. E. T., Rourke, J. L., Sinal, C. J., Seitz, B. M., Sullivan, T. J., Charvat, T. T., Thompson, J., Burnett, R. J., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301476 · Cited by 148 · see citing works
Vascular Effects of Novel Adipocytokines: Focus on Vascular Contractility and Inflammatory Responses
Yamawaki, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.307 · Cited by 142 · see citing works
Yilmaz, Y. N., Yönal, O., Kurt, R., Alahdab, Y. Ö., Eren, F., Ozdogan, O. C., Çelikel, Ç., İmeryüz, N., Kalaycı, C., & Avşar, E. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.516452 · Cited by 131 · see citing works
White adipose tissue and cardiovascular disease
Matsuzawa, Y. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.001 · Cited by 119 · see citing works
Tabet, F., Schiffrin, E. L., Callera, G. E., He, Y., Yao, G., Östman, A., Kappert, K., Tonks, N. K., & Touyz, R. M. (2008) · Circulation Research · doi:10.1161/circresaha.108.178608 · Cited by 107 · see citing works
Self-citationA novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells
Yamawaki, H., Kameshima, S., Usui, T., Okada, M., & Hara, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.103 · Cited by 90 · see citing works
Carlino, C., Trotta, E., Stabile, H., Morrone, S., Bulla, R., Soriani, A., Iannitto, M. L., Agostinis, C., Mocci, C., Minozzi, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1102 · Cited by 90 · see citing works
NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?
van Heerebeek, L., Meischl, C., Stooker, W., Meijer, C. J. L. M., Niessen, H. W. M., & Roos, D. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.8.561 · Cited by 83 · see citing works
Oxidative stress mediates chemerin-induced autophagy in endothelial cells
Shen, W., Tian, C., Chen, H., Yang, Y., Zhu, D., Gao, P., & Liu, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.011 · Cited by 83 · see citing works
Neves, K. B., Lobato, N. S., Alves-Lopes, R., Filgueira, F. P., Zanotto, C. Z., de Oliveira, A. M., & Tostes, R. C. (2014) · Clinical Science · doi:10.1042/cs20130286 · Cited by 78 · see citing works
Self-citationCatalán, V., Gómez‐Ambrosi, J., Rodrı́guez, A., Ramírez, B., Rotellar, F., Valentí, V., Silva, C., Gil, M. J., Salvador, J., & Frühbeck, G. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.11.001 · Cited by 76 · see citing works
Redox balance dynamically regulates vascular growth and remodeling
Bir, S. C., Kolluru, G. K., Fang, K., & Kevil, C. G. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.05.003 · Cited by 68 · see citing works
Chemerin, vaspin and insulin resistance in chronic hepatitis C
Kukla, M., Żwirska-Korczala, K., Gabriel, A., Waluga, M., Warakomska, I., Szczygieł, B., Berdowska, A., Mazur, W., Woźniak-Grygiel, E., & Kryczka, W. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01224.x · Cited by 68 · see citing works
Lobato, N. S., Neves, K. B., Filgueira, F. P., Fortes, Z. B., de Carvalho, M. H. C., Webb, R. C., de Oliveira, A. M., & Tostes, R. C. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.04.013 · Cited by 57 · see citing works
Self-citationChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation
Rouger, L., Denis, R., Luangsay, S., & Parmentier, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0106 · Cited by 57 · see citing works
Yang, H., Li, F., Kong, X., Yuan, X., Wang, W., Huang, R., Li, T., Geng, M., Wu, G., & Yin, Y. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.033 · Cited by 56 · see citing works
Clinical importance of an elevated circulating chemerin level in incident dialysis patients
Yamamoto, T., Qureshi, A. R., Anderstam, B., Heimbürger, O., Barany, P. F., Lindholm, B., Stenvinkel, P., & Axelsson, J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq329 · Cited by 52 · see citing works
Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis
Issa, M. E., Muruganandan, S., Ernst, M. C., Parlee, S. D., Zabel, B. A., Butcher, E. C., Sinal, C. J., & Goralski, K. B. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00187.2011 · Cited by 47 · see citing works
Increased serum chemerin concentration in patients with chronic pancreatitis
Adrych, K., Stojek, M., Smoczyński, M., Śledziński, T., Szrok-Jurga, S., & Świerczyński, J. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.06.020 · Cited by 40 · see citing works
Herová, M., Schmid, M., Gemperle, C., Loretz, C., & Hersberger, M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.912 · Cited by 37 · see citing works
Evaluation of plasma chemerin levels in patients with non-dipper blood pressure patterns
Adem, U. (2014) · Medical Science Monitor · doi:10.12659/msm.890784 · Cited by 23 · see citing works
Barbero (2014) · doi:10.1016/j · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [3]3. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. [The adipose tissue as a regulatory center of the metabolism]. Arq Bras Endocrinol Metabol . 2006;50:216-229. doi: /S0004-27302006000200008.
Cited by
Sorted by citations
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937 · see citing works
Oxidative Stress, Inflammation, and Vascular Aging in Hypertension
Guzik, T. J., & Touyz, R. M. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.07802 · Cited by 772 · see citing works
Self-citationVascular smooth muscle contraction in hypertension
Touyz, R. M., Alves-Lopes, R., Rios, F. J. O., Camargo, L. L., Anagnostopoulou, A., Arner, A., & Montezano, A. C. I. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy023 · Cited by 704 · see citing works
Self-citationVascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications
Harvey, A., Montezano, A. C. I., Alves-Lopes, R., Rios, F. J. O., & Touyz, R. M. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.070 · Cited by 385 · see citing works
Self-citationBeyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 337 · see citing works
Chemerin: a multifaceted adipokine involved in metabolic disorders
Helfer, G., & Wu, Q. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0174 · Cited by 317 · see citing works
The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.055 · Cited by 190 · see citing works
The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases
Izzo, C., Vitillo, P., Pietro, P. D., Visco, V., Strianese, A., Virtuoso, N., Ciccarelli, M., Galasso, G., Carrizzo, A., & Vecchione, C. (2021) · Life · doi:10.3390/life11010060 · Cited by 167 · see citing works
Adipokines and Inflammation: Focus on Cardiovascular Diseases
Feijóo‐Bandín, S., Aragón‐Herrera, A., Moraña‐Fernández, S., Anido‐Varela, L., Tarazón, E., Roselló‐Lletí, E., Portolés, M., Moscoso, I., Gualillo, O., González‐Juanatey, J. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207711 · Cited by 122 · see citing works
Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in Obesity
da Costa, R. M., Neves, K. B., Tostes, R. C., & Lobato, N. S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00253 · Cited by 107 · see citing works
Self-citationDeVallance, E., Li, Y., Jurczak, M. J., Cifuentes-Pagano, E., & Pagano, P. J. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7674 · Cited by 99 · see citing works
Touyz, R. M., Anagnostopoulou, A., Camargo, L. L., Rios, F. J. O., & Montezano, A. C. I. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7583 · Cited by 91 · see citing works
Self-citationZylla, S., Pietzner, M., Kühn, J., Völzke, H., Dörr, M., Nauck, M. A., & Friedrich, N. (2017) · Obesity · doi:10.1002/oby.21735 · Cited by 90 · see citing works
Inflammatory Cytokines as Uremic Toxins: “Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son”
Castillo-Rodríguez, E., Pizarro-Sánchez, M. S., Sanz, A. B., Ramos, A. M., Sánchez-Niño, M. D., Martín-Cleary, C., Fernández‐Fernández, B., & Ortíz, A. (2017) · Toxins · doi:10.3390/toxins9040114 · Cited by 85 · see citing works
Role of Perivascular Adipose Tissue in Vascular Physiology and Pathology
Cao, Z. F. H., Stoffel, E., & Cohen, P. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08451 · Cited by 87 · see citing works
Drug Treatment of Hypertension: Focus on Vascular Health
Cameron, A. C., Lang, N. N., & Touyz, R. M. (2016) · Drugs · doi:10.1007/s40265-016-0642-8 · Cited by 83 · see citing works
Self-citationHood, K. Y., Montezano, A. C. I., Harvey, A., Nilsen, M., MacLean, M. R., & Touyz, R. M. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07668 · Cited by 80 · see citing works
Self-citationDimitriadis, G. K., Kaur, J., Adya, R., Miras, A. D., Mattu, H. S., Hattersley, J. G., Kaltsas, G., Tan, B. K., & Randeva, H. S. (2018) · Oncotarget · doi:10.18632/oncotarget.24659 · Cited by 73 · see citing works
Lefranc, C., Friederich‐Persson, M., Braud, L., Palacios, R., Karlsson, S., Boujardine, N., Motterlini, R., Jaisser, F., & Cat, A. N. D. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11873 · Cited by 70 · see citing works
Zhang, Y., Xu, N., Ding, Y. P., Doycheva, D. M., Zhang, Y., Li, Q., Flores, J. J., Haghighiabyaneh, M., Tang, J., & Zhang, J. H. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1374-y · Cited by 69 · see citing works
RetractedDludla, P. V., Dias, S. C., Obonye, N., Johnson, R., Louw, J., & Nkambule, B. B. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0275-2 · Cited by 66 · see citing works
New drug targets for hypertension: A literature review
Gao, Q., Xu, L., & Cai, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166037 · Cited by 62 · see citing works
Targeting obesity and diabetes to treat heart failure with preserved ejection fraction
Altara, R., Giordano, M., Nordén, E. S., Cataliotti, A., Kurdi, M., Bajestani, S. N., & Booz, G. W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00160 · Cited by 61 · see citing works
The Local Regulation of Vascular Function: From an Inside-Outside to an Outside-Inside Model
Nava, E., & Llorens, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00729 · Cited by 62 · see citing works
Tan, L., Lu, X., Danser, A. H. J., & Verdonk, K. (2023) · Nutrients · doi:10.3390/nu15132878 · Cited by 59 · see citing works
Zhang, J., Liu, L., Zhang, Y., Yuan, Y., Miao, Z., Lu, K., Zhang, X., Ni, R., Zhang, H., Zhao, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102554 · Cited by 58 · see citing works
Chemerin as a Driver of Hypertension: A Consideration
Ferland, D. J., Mullick, A. E., & Watts, S. W. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa084 · Cited by 57 · see citing works
da Silva, J. F., Alves, J. V., da Silva-Neto, J. A., da Costa, R. M., Neves, K. B., Alves-Lopes, R., Carmargo, L. L., Rios, F. J. O., Montezano, A. C. I., Touyz, R. M., et al. (2021) · Clinical Science · doi:10.1042/cs20210468 · Cited by 54 · see citing works
Self-citationChemerin: A Functional Adipokine in Reproductive Health and Diseases
Yu, M., Yang, Y., Huang, C. Y., Ge, L., Xue, L., Xiao, Z., Xiao, T., Zhao, H., Ren, P., & Zhang, J. V. (2022) · Biomedicines · doi:10.3390/biomedicines10081910 · Cited by 52 · see citing works
Role of Chemerin in Cardiovascular Diseases
Mačvanin, M., Rizzo, M., Radovanović, J., Sönmez, A., Paneni, F., & Isenović, E. R. (2022) · Biomedicines · doi:10.3390/biomedicines10112970 · Cited by 43 · see citing works
Xie, Y., & Liu, L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-021-03220-7 · Cited by 41 · see citing works
Prochemerin cleavage by factor XIa links coagulation and inflammation
Ge, X., Yamaguchi, Y., Zhao, L., Bury, L., Gresele, P., Berube, C., Leung, L. L. K., & Morser, J. (2017) · Blood · doi:10.1182/blood-2017-07-792580 · Cited by 40 · see citing works
Zou, R., Wang, M.-H., Chen, Y., Fan, X., Yang, B., Du, J., Wang, X., Liu, K., & Zhou, J. F. (2018) · Shock · doi:10.1097/shk.0000000000001194 · Cited by 39 · see citing works
Chemerin in renal dysfunction and cardiovascular disease
Bonomini, M., & Pandolfi, A. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.10.007 · Cited by 38 · see citing works
The paracrine control of vascular motion. A historical perspective
Nava, E., & Llorens, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.003 · Cited by 36 · see citing works
Endothelial Nitric Oxide Synthase in the Perivascular Adipose Tissue
Man, A. W. C., Zhou, Y., Xia, N., & Li, H. (2022) · Biomedicines · doi:10.3390/biomedicines10071754 · Cited by 37 · see citing works
Abais‐Battad, J. M., Lund, H., Fehrenbach, D. J., Dasinger, J. H., Alsheikh, A. J., & Mattson, D. L. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11994 · Cited by 33 · see citing works
Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling
Liu, G., Wan, N., Liu, Q., Chen, Y., Cui, H., Wang, Y., Ren, J., Shen, X., Lu, W., Yu, Y., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17809 · Cited by 35 · see citing works
Effects of chemerin/CMKLR1 in obesity-induced hypertension and potential mechanism.
Weng, C., Shen, Z., Li, X., Jiang, W., Peng, L., Yuan, H., Yang, K., & Wang, J. (2017) · PubMed Central · Cited by 35 · see citing works
Sun, J.-X., Zhang, C., Cheng, Z.-B., Tang, M.-Y., Liu, Y., Jiang, J.-F., Xiao, X., & Huang, L. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.05.015 · Cited by 34 · see citing works
Dellepiane, S., Medica, D., Guarena, C., Musso, T., Quercia, A. D., Leonardi, G., Marengo, M., MIGLIORI, M., Panichi, V., Biancone, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47040-8 · Cited by 33 · see citing works
Force-sensing protein expression in response to cardiovascular mechanotransduction
Wang, Y.-T., Chatterjee, E., Li, G., Xu, J., & Xiao, J. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105412 · Cited by 32 · see citing works
Jiang, Y., Liu, P., Jiao, W., Meng, J., & Feng, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25918 · Cited by 32 · see citing works
Wen, J., Wang, J., Guo, L. P., Cai, W., Wu, Y., Chen, W., & Tang, X. (2019) · Europe PMC (PubMed Central) · Cited by 31 · see citing works
Multifaced roles of adipokines in endothelial cell function
Yan, Y., Wang, L., Zhong, N., Wen, D., & Liu, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1490143 · Cited by 30 · see citing works
Er, L., Wu, S., Hsu, L., Teng, M., Sun, Y.-C., & Ko, Y. (2018) · Mediators of Inflammation · doi:10.1155/2018/4670521 · Cited by 30 · see citing works
Adipokine Chemerin Stimulates Progression of Atherosclerosis in ApoE−/− Mice
Liu, H., Xiong, W., Luo, Y., Chen, H., He, Y., Cao, Y., & Dong, S. (2019) · BioMed Research International · doi:10.1155/2019/7157865 · Cited by 29 · see citing works
Auclair, A., Biertho, L. D., Marceau, S., Hould, F., Biron, S., Lebel, S., Julien, F., Lescelleur, O., Lacasse, Y., Piché, M., et al. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2737-z · Cited by 29 · see citing works
G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis
van der Vorst, E. P. C., Peters, L. J. F., Müller, M., Gencer, S., Yan, Y., Weber, C., & Döring, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00531 · Cited by 29 · see citing works
Watts, S. W., Darios, E. S., Mullick, A. E., Garver, H. S., Saunders, T. L., Hughes, E. D., Filipiak, W. E., Zeidler, M. G., McMullen, N. M., Sinal, C. J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800479 · Cited by 28 · see citing works
Adipokines: Deciphering the cardiovascular signature of adipose tissue
Galley, J. C., Singh, S., Awata, W. M. C., Alves, J. V., & Bruder-Nascimento, T. B. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115324 · Cited by 28 · see citing works
Man, A. W. C., Zhou, Y., Reifenberg, G., Camp, A., Münzel, T. F., Daiber, A., Xia, N., & Li, H. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad164 · Cited by 27 · see citing works
The adventitia in arterial development, remodeling, and hypertension
Majesky, M. W., & Weiser‐Evans, M. C. M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115259 · Cited by 26 · see citing works
Gu, P., Wang, W., Yao, Y., Xu, Y., Wang, L., Zang, P., Ma, J., Yang, C., Liang, J., Lü, B., et al. (2019) · International Journal of Endocrinology · doi:10.1155/2019/8693516 · Cited by 25 · see citing works
Regan-Komito, D., Valaris, S., Kapellos, T. S., Recio, C., Taylor, L., Greaves, D. R., & Iqbal, A. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01621 · Cited by 23 · see citing works
Association of Circulating Chemerin With Subclinical Parameters of Atherosclerosis
Zylla, S., Dörr, M., Völzke, H., Schminke, U., Felix, S. B., Nauck, M. A., & Friedrich, N. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311219 · Cited by 25 · see citing works
Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia
Tan, L., Kluivers, A. C. M., Cruz‐López, E. O., Broekhuizen, M., Chen, Z., Neuman, R. I., Schoenmakers, S., Ruijgrok, E. J., van de Velde, D., de Winter, B. C. M., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.22457 · Cited by 24 · see citing works
Immunometabolic Regulation of Vascular Redox State: The Role of Adipose Tissue
Oikonomou, E. K., & Antoniades, C. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7017 · Cited by 24 · see citing works
Skuratovskaia, D., Затолокин, П. А., Vulf, M., Mazunin, I., & Litvinova, L. S. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0485-8 · Cited by 21 · see citing works
Chemerin influences endothelin- and serotonin-induced pulmonary artery vasoconstriction in rats
Hanthazi, A., Jespers, P., Vegh, G., Degroot, G.-N., Springael, J., Lybaert, P., Dewachter, L., & Entee, K. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116580 · Cited by 21 · see citing works
Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
Bettinetti‐Luque, M., Trujillo‐Estrada, L., García‐Fuentes, E., Andreo‐Lopez, J., Sanchez-Varo, R. M., Garrido‐Sánchez, L., Mediavilla, A. G., López, M. G., García‐Caballero, M., Gutiérrez, A., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16243 · Cited by 21 · see citing works
Perivascular adipose tissue in autoimmune rheumatic diseases
Shi, H., Wu, H., Winkler, M. A., de Chantemèle, E. J. B., Lee, R., Kim, H. W., & Weintraub, N. L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106354 · Cited by 19 · see citing works
Pharmacological and physiological roles of adipokines and myokines in metabolic-related dementia
Arjunan, A., & Song, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114847 · Cited by 19 · see citing works
Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
Aydın, K., Canpolat, U., Akın, Ş., Dural, M., Karakaya, J., Aytemir, K., Ozer, N., & Gürlek, A. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2015.6629 · Cited by 19 · see citing works
Inflammation as a mediator of arterial ageing
Trott, D. W., & Fadel, P. J. (2019) · Experimental Physiology · doi:10.1113/ep087499 · Cited by 19 · see citing works
Activation of the Coagulation Cascade as a Universal Danger Sign
Старикова, Э. А., Mammedova, J. T., Rubinstein, A., Av, S., & Kudryavtsev, I. V. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020108 · Cited by 18 · see citing works
Man, A. W. C., Xia, N., & Li, H. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02814-5 · Cited by 18 · see citing works
Lu, Z., Liu, J., Wan, Q., Wu, Y. F., Wu, W., & Chen, Y. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09359-y · Cited by 18 · see citing works
Tolusso, B., Alivernini, S., Gigante, M. R., Ferraccioli, G., & Gremese, E. (2016) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2016.1159132 · Cited by 17 · see citing works
Zhang, R., & Wang, Q. (2020) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2020.151416 · Cited by 17 · see citing works
Özcan, E., Saygun, N., Sağkan, R. I., Karslıoğlu, Y., Muşabak, U., & Yeşillik, S. (2017) · Odontology · doi:10.1007/s10266-017-0297-2 · Cited by 16 · see citing works
Lu, P., Huang, X., Jin, X., Zuo, J. L., Yang, L., Zhou, Y., Ren, J., & Zhao, Y. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.011 · Cited by 16 · see citing works
Alves-Lopes, R., Neves, K. B., Strembitska, A., Harvey, A., Harvey, K. Y., Yusuf, H., Haniford, S., Hepburn, R., Dyet, J., Beattie, W., et al. (2021) · Clinical Science · doi:10.1042/cs20210643 · Cited by 12 · see citing works
Self-citationZhang, R., Wang, Q., & Yang, L. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29269 · Cited by 14 · see citing works
Chemerin as a Driver of Cardiovascular Diseases: New Perspectives and Future Directions
Imiela, A. M., Stępnicki, J., Zawadzka, P. S., Bursa, A., & Pruszczyk, P. (2025) · Biomedicines · doi:10.3390/biomedicines13061481 · Cited by 13 · see citing works
Hanthazi, A., Jespers, P., Vegh, G., Dubois, C., Hubesch, G., Springael, J., Dewachter, L., & Entee, K. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00926 · Cited by 13 · see citing works
Berryman, D. E., Henry, B. E., Hjortebjerg, R., List, E. O., & Kopchick, J. J. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1147950 · Cited by 12 · see citing works
Lin, X., Qu, J., Yin, L., Wang, R., & Wang, X. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159409 · Cited by 11 · see citing works
Obesity and the obesity paradox in abdominal aortic aneurysm
Lu, F., Lin, Y., Zhou, J., Chen, Z., Liu, Y., Zhong, M., & Wang, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1410369 · Cited by 11 · see citing works
Adipose tissue secretory profile and cardiometabolic risk in obesity
Zhang, P., Konja, D., & Wang, Y. (2020) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100061 · Cited by 11 · see citing works
Arterial Hypertension: Novel Pharmacological Targets and Future Perspectives
Popa, I. P., Clim, A., Pînzariu, A. C., Lazăr, C. I., Popa, Ș., Tudorancea, I. M., Moscalu, M., Șerban, D. N., Șerban, I. L., Costache-Enache, I.-I., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195927 · Cited by 10 · see citing works
Chemokine-Like Receptor 1 Regulates the Proliferation and Migration of Vascular Smooth Muscle Cells
Liu, H., Xiong, W. G., Liu, Q., Zhang, J., & Dong, S. (2016) · Medical Science Monitor · doi:10.12659/msm.897832 · Cited by 9 · see citing works
Thrombin in the Crossroad Hemostasis and Inflammation
Старикова, Э. А., Mammedova, J. T., & Porembskaya, О. Y. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023050216 · Cited by 8 · see citing works
Dahpy, M. A., Khairallah, M. K., Azoz, N. M. A., & Ezzat, G. M. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00063-7 · Cited by 8 · see citing works
Wang, B., Ni, J., Yu, L., Chen, S., Shang, W., Fang, P., & Wen, M. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112465 · Cited by 6 · see citing works
Chemerin Is the Adipokine Linked with Endothelin-Dependent Vasoconstriction in Human Obesity
Schinzari, F., Montenero, R., Cardillo, C., & Tesauro, M. (2025) · Biomedicines · doi:10.3390/biomedicines13092131 · Cited by 5 · see citing works
Tan, L., Wang, N., Galema‐Boers, A. M. H., der Zee, L. V. V., van Lennep, J. E. R., Mulder, M. T., Lu, X., Danser, A. H. J., & Verdonk, K. (2024) · MedComm · doi:10.1002/mco2.681 · Cited by 4 · see citing works
Jerang, M., Kumar, R. K., Gurusubramanian, G., & Roy, V. K. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102374 · Cited by 4 · see citing works
Li, J., Song, L., & Hui, S. (2021) · Europe PMC (PubMed Central) · Cited by 4 · see citing works
Watts, S. W. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05738 · Cited by 4 · see citing works
Ahmed, N. A., Hussein, A. A., Khalil, R. G., Yassin, N. Y. S., Abdelaziz, M. A., Geddawy, A., & Ahmed, O. M. (2026) · Biochemistry Research International · doi:10.1155/bri/1761697 · Cited by 3 · see citing works
The chemerin production changes in obese patients with different carbohydrate metabolism state
Василенко, М. А., Кириенкова, Е. В., Skuratovskaia, D., Затолокин, П. А., Mironyuk, N. I., & Litvinova, L. S. (2017) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20176306582 · Cited by 3 · see citing works
Adipolin, Chemerin, Neprilysin and Metabolic Disorders Associated with Obesity
Sperling, M., Grzelak, T., Pelczyńska, M., Bogdański, P., Czyżewska, K., & Formanowicz, D. (2023) · Applied Sciences · doi:10.3390/app13148005 · Cited by 2 · see citing works
Stein, D., Ovadia, D., Katz, S. D., & Brar, P. C. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2023-0339 · Cited by 2 · see citing works
The vascular phenotype in hypertension
Touyz, R. M., Rios, F. J. O., Montezano, A. C. I., Neves, K. B., Eluwole, O. A., Maseko, M. J., Alves-Lopes, R., & Camargo, L. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822546-2.00022-8 · Cited by 2 · see citing works
Self-citationThrombin in the Crossroad Hemostasis and Inflammation
Старикова, Э. А., Mammedova, J. T., & Porembskaya, О. Y. (2023) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813923100114 · Cited by 2 · see citing works
Human chemerin induces eryptosis at concentrations exceeding circulating levels
Tkachenko, M., ONISHCHENKO, A., Tryfonyuk, L., Butov, D., Kot, K., NOVIKOVA, V., FAN, L., Prokopіuk, V., Kot, Y. G., & Tkachenko, A. S. (2024) · Biocell · doi:10.32604/biocell.2024.050206 · Cited by 2 · see citing works
Salah, N. Y., Madkour, S. S., Ahmed, K., Abdelhakam, D. A., Abdullah, F. A., & Mahmoud, R. A. A. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02215-z · Cited by 1 · see citing works
Kuyumcu, A., & Kuyumcu, M. S. (2025) · Kardiologiia · doi:10.18087/cardio.2025.5.n2888 · Cited by 1 · see citing works
- Authors
- Neves, K. B., Nguyen Dinh Cat, A., Lopes, R. A. M., Rios, F. J., Anagnostopoulou, A., Lobato, N. S., de Oliveira, A. M., Tostes, R. C., Montezano, A. C., & Touyz, R. M.
- Affiliations
- Universidade de São Paulo (BR)
- From the Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, College of Medicine, Veterinary and Life Sciences, University of Glasgow (K.B.N., A.N.D.C., R.A.M.L., F.J.R., A.A., A.C.M., R.M.T.); Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirao Preto (K.B.N., A.M.d.O.) and Department of Pharmacology (R.A.M.L., R.C.T.), University of Sao Paulo, Ribeirao Preto, SP, Brazil; and Department of Biological Sciences, Federal...
- Corresponding author
- Touyz, Rhian M.
- ORCID
- Venue
- Hypertension
- Published
- 2015-09
- Volume
- 66
- Issue
- 3
- Pages
- 657-666
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2152629111
- Cited by
- 113
- References
- 51
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 8 · 2019: 16 · 2018: 12 · 2017: 14 · 2016: 8 · 2015: 4
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion)
- Funders
- British Heart Foundation (29762, RG/13/7/30099, 30099)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- chemerin, NADPH oxidase, adipocytes, vascular smooth muscle cells, microvascular endothelial cells, reactive oxygen species, MAPK signaling, apoptosis, inflammation, cell proliferation, endothelial nitric oxide synthase, nitric oxide, adipokines, obesity, vascular injury, type 2 diabetes
- MeSH terms
- Cell Communication, Endothelium, Vascular, Humans, Muscle, Smooth, Vascular, Phosphorylation, Apoptosis, Reactive Oxygen Species, Adipocytes, Chemokines, Myocytes, Smooth Muscle, Intercellular Signaling Peptides and Proteins, Endothelial Cells, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
